LFSC:NSD-F/m Emerald Life Sciences Innovation ETF (USD)

ETF | Others |

Last Closing

USD 22.6178

Change

-0.61 (-2.64)%

Market Cap

USD 0.05B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.25 (-2.60%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

-3.28 (-1.65%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.73 (-1.38%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

-0.85 (-0.72%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

-0.03 (-0.17%)

USD 16.14B
SNDK Sandisk Corp

+0.77 (+1.38%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 5.17B
NVDL GraniteShares 1.5x Long NVDA D..

-3.03 (-6.63%)

USD 3.76B
ETHA iShares Ethereum Trust ETF

-0.30 (-2.04%)

USD 3.75B
TSLL Direxion Shares ETF Trust - Di..

-0.87 (-10.43%)

USD 3.11B

ETFs Containing LFSC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.31% 35% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.31% 35% F 54% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.05B 57% F 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike